Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events rti named leader diversity
Real-World Comparative Effectiveness Analysis for Use in Cost-Effectiveness Modeling in Multiple Sclerosis …
Health Economics and Outcomes Research (HEOR) Strategy Plans and Gap Analyses for a Treatment Targeting Multiple Rare Diseases OPPORTUNITY Our client had a product in multiple phase 2 and 3 clinical trials for the treatment of numerous rare disease …
Integrated Real-World Clinical and Economic Evaluation of Treatment Alternatives OPPORTUNITY Disease-modifying therapies (DMTs) have been shown to reduce relapses and delay disability progression for people living with multiple sclerosis (MS). Our client …
Identifying Psychosis in Patients with Dementia Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the Challenge Really Exists Joan Forns , J Bradley Layton , and Mary E Ritchey Transcript: Psychosis is a common …
Oncology A Wealth of Experience We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes: Basal cell carcinoma Bladder cancer Breast cancer Cervical …
Antidepressant Drug Utilization Study Antidepressant Use in Denmark, Germany, Spain, and Sweden from 2009 to 2014: Incidence and Comorbidities of Antidepressant Initiators Joan Forns , Anton Pottegård, Tammo Reinders, Beatriz Poblador-Plou, Rosa Morros, …
Best Practices for Interacting with ICER A systematic review of ICER evaluations from 2008 to 2018: recent trends in evaluation process and lessons learned Ronquest NA, Gould IG, Barnett CL, Mladsi DM Transcript: The Institute for Clinical and Economic …
Including Carer Utility Values in HTAs The Inclusion of the Utility Values for Carers and Family Members in HTAs: a Case Study of Recent NICE Appraisals in the UK Basarir H, Brockbank J, Knight C, Wolowacz S. Transcript: Caring for a family member or …
Psychiatry A Wealth of Experience We have collaborated with our clients on projects to research psychiatric and mental health illnesses, treatments, and complications and comorbidities of psychiatric and mental health illnesses. Our experience includes: …
How Much Does TLV Value Rarity? A Review of Reimbursement Maria Kinderås, MSc Senior Associate, Market Access and Outcomes Strategy Transcript Orphan drug reimbursement continues to pose significant challenges for Swedish decision-makers – due often to …